Search by Drug Name or NDC
NDC 65862-0626-36 Rizatriptan Benzoate 10 mg/1 Details
Rizatriptan Benzoate 10 mg/1
Rizatriptan Benzoate is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is RIZATRIPTAN BENZOATE.
MedlinePlus Drug Summary
Rizatriptan is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Rizatriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Rizatriptan does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 65862-0626-36Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Rizatriptan
Product Information
| NDC | 65862-0626 |
|---|---|
| Product ID | 65862-626_a145439e-ef26-4622-a164-d9ca7148eaf9 |
| Associated GPIs | 67406060107230 |
| GCN Sequence Number | 040224 |
| GCN Sequence Number Description | rizatriptan benzoate TAB RAPDIS 10 MG ORAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 19594 |
| HICL Sequence Number | 018535 |
| HICL Sequence Number Description | RIZATRIPTAN BENZOATE |
| Brand/Generic | Generic |
| Proprietary Name | Rizatriptan Benzoate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Rizatriptan Benzoate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | RIZATRIPTAN BENZOATE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203062 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0626-36 (65862062636)
| NDC Package Code | 65862-626-36 |
|---|---|
| Billing NDC | 65862062636 |
| Package | 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-626-36) |
| Marketing Start Date | 2018-03-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |